News Center

Is Apple’s Services business more vulnerable than ever?

Is Apple’s Services business more vulnerable than ever?

Investing.com -- Apple’s Services division, long considered a pillar of stability, has recently been facing heightened scrutiny from investors amid legal, competitive, and regulatory challenges that could undermine its growth profile and premium valuation.According to Morgan Stanley, the April 30 injunction tied to the App Store and comments made by Apple (NASDAQ:AAPL) Services head Eddy Cue dur ...

2025-05-18 19:48:11
Analyst lists 3 things he learnt at a major power semiconductor conference

Analyst lists 3 things he learnt at a major power semiconductor conference

Investing.com -- UBS analyst Francois-Xavier Bouvignies shared three key takeaways from the PCIM 2025 power electronics conference held in Nuremberg.The analyst highlighted intensifying Chinese competition, improving inventory conditions, and the accelerating adoption of next-gen technologies like gallium nitride (GaN).Competition from China is intensifying: UBS noted that concerns raised las ...

2025-05-18 19:47:02
Trump administration is concerned by deal to put Alibaba’s AI on iPhones, NYT reports

Trump administration is concerned by deal to put Alibaba’s AI on iPhones, NYT reports

(Reuters) -The White House and congressional officials have been scrutinizing Apple (NASDAQ:AAPL)’s plan to strike a deal with Alibaba (NYSE:BABA) to make the Chinese company’s AI available on iPhones in China, The New York Times (NYSE:NYT) reported on Saturday. U.S. authorities were concerned that the deal would help a Chinese company to improve its artificial intelligence capacities, bro ...

2025-05-18 19:45:54
How will GLP-1s impact the market for diabetes stocks? Berstein weighs in

How will GLP-1s impact the market for diabetes stocks? Berstein weighs in

Investing.com - Diabetes technology stocks have seen investor worries all but "vanish" over the possible negative implications of the emergence of popular obesity drugs, although it remains to be seen if this is a "false sense of security", according to analysts at Bernstein.A 2023 test showing that Novo Nordisk (NYSE:NVO)’s Wegovy weight-loss medication not only helped people lose weight b ...

2025-05-18 19:44:44